Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone in Optic Neuritis
NCT05540262Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of edaravone in optic neuritis (ON), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Best-Corrected Visual Acuity at 18 months. Started Jan 2022; status: recruiting.
02
Drugs
edaravone
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT05540262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540262.